Closed: Enabling novel E3 ligases for targeted protein degradation therapeutics
Primary site:
Sutton
Funded by
Medical Research Council - Doctoral Training Partnership (MRC DTP)
OPEN: Immunopeptidome landscape of multiple myeloma
Primary supervisor: Professor Richard Houlston
Primary site:
Sutton
Funded by
ICR
Closed: Developing novel mRNA vaccines against cancer associated mis-splicing events to enhance therapy response
Primary supervisor: Dr Rachael Natrajan
Primary site:
Sutton
Funded by
Medical Research Council - Doctoral Training Partnership (MRC DTP)
Closed: Development of a microbeam-FLASH irradiator for pre-clinical radiation therapy research
Primary supervisor: Professor Uwe Oelfke
Primary site:
Sutton
Funded by
ICR
Closed: Decoding the ALT Pathway: Identifying Synthetic Lethal Targets and Biomarkers for Precision Cancer Therapy
Primary supervisor: Professor Wojciech Niedzwiedz
Primary site:
Chelsea
Funded by
MRC iCASE Award (Merck)
Closed: Deciphering the role of human papillomavirus (HPV) in radiotherapy resistance for HPV+ head and neck cancers
Primary supervisor: Dr Ben O'Leary
Primary site:
Sutton
Funded by
ICR
Closed: Structural study of cotranscriptional spliceosomes stalled by antitumor compounds
Primary supervisor: Professor Vlad Pena
Primary site:
Chelsea
Funded by
Medical Research Council - Doctoral Training Partnership (MRC DTP)
Closed: Exploring the interplay between histone acetyltransferase complexes in acute myeloid leukaemia
Primary supervisor: Dr Alex Radzisheuskaya
Primary site:
Chelsea
Funded by
Medical Research Council - Doctoral Training Partnership (MRC DTP)
Closed: Metabolic MRI of paediatric-type diffuse high grade glioma and its response to therapy in vivo
Primary supervisor: Professor Simon Robinson
Primary site:
Sutton
Funded by
Medical Research Council - Doctoral Training Partnership (MRC DTP)
Closed: Developing Direct-to-Biology for Molecular Glue Discovery
Primary supervisor: Professor Zoran Rankovic
Primary site:
Sutton
Funded by
MRC iCASE award (AstraZeneca)
Closed: Uncovering mutational processes associated to immune surveillance during breast cancer development and therapeutic interventions
Primary supervisor: Dr Luis Zapata Ortiz
Primary site:
Sutton
Funded by
ICR
Closed: Determining the role of the adaptive immune system in controlling breast cancer metastasis and evolution
Primary supervisor: Dr Stephen-John Sammut
Primary site:
Chelsea
Funded by
Medical Research Council - Doctoral Training Partnership (MRC DTP)
